表紙:冠動脈ステントの世界市場:市場規模、シェア、動向分析 - 製品(ベアメタルステント、薬剤溶出ステント、生体吸収性血管スキャフォールド)、地域別
市場調査レポート
商品コード
374559

冠動脈ステントの世界市場:市場規模、シェア、動向分析 - 製品(ベアメタルステント、薬剤溶出ステント、生体吸収性血管スキャフォールド)、地域別

Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 110 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.12円
冠動脈ステントの世界市場:市場規模、シェア、動向分析 - 製品(ベアメタルステント、薬剤溶出ステント、生体吸収性血管スキャフォールド)、地域別
出版日: 2020年03月16日
発行: Grand View Research, Inc.
ページ情報: 英文 110 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の冠動脈ステント市場は、2020年から2027年にかけて4.7%のCAGRで推移し2027年までに113億米ドル規模の市場に成長すると予測されています。低侵襲手術や経皮的冠動脈インターベンション(PIC)の採用の増加、高齢者人口の増加、第2世代薬剤溶出性ステント(DES)の技術的進歩、ポリマー非含有の生分解性薬剤溶出ステント(DES)の開発などが当市場の成長を促進する見通しです。

当レポートでは、世界の冠動脈ステント市場を調査し、市場の概要、製品・地域別の市場規模の推移と予測、市場シェア、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査手法

  • 調査手法
  • 情報調達
  • データ分析
  • 市場形成と検証
  • モデル詳細
  • 2次情報源のリスト
  • 1次情報源のリスト
  • 略語
  • 調査目的

第2章 エグゼクティブサマリー

  • 市場スナップショット

第3章 業界見通し

  • 市場セグメンテーション
  • 市場系統の見通し
  • 市場力学
    • 成長要因の分析
    • 阻害要因の分析
    • 課題
  • 浸透と成長の見通しマッピング
  • ユーザー視点分析
    • 消費者行動の分析
    • 市場インフルエンサーの分析
  • 価格分析
  • 技術概要
  • 規制の枠組み
  • 製品パイプライン/臨床試験の分析
  • 研究開発費分析
  • 研究開発費の分析
  • 製品のリコール
  • ビジネス環境分析ツール
    • SWOT分析
    • ファイブフォース分析

第4章 競合情勢

  • 参入企業の区分
  • コンペティションダッシュボード
  • 革新的企業
  • 公開会社
  • ベンダー情勢

第5章 冠動脈ステント市場の分析:製品別

  • 市場動向の分析:製品別
  • ベアメタルステント
  • 薬剤溶出性ステント
  • 生体吸収性血管スキャフォールド

第6章 冠動脈ステント市場の分析:地域別

  • 市場シェア:地域別(実績値・予測値)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 企業プロファイル

  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • テルモ
  • B Braun Melsungen AG
  • Biotronik
  • Stentys SA
  • MicroPort Scientific Corporation
  • C. R. Bard, Inc.
  • Cook Medical
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 CPT Coding
  • Table 4 HCPCS Coding
  • Table 5 CMS new reimbursement coding for PCI
  • Table 6 Product pipeline/clinical stage
  • Table 7 R&D expenditure analysis of public companies (2018)
  • Table 8 Leading market players anticipated to witness highest growth
  • Table 9 List of coronary stents service providers
  • Table 10 Leading cause of death in elderly population in the U.S. in 2019
  • Table 11 North America Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 12 U.S. Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 13 Canada Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 14 Europe Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 15 U.K. Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 16 Germany Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 17 France Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 18 Italy Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 19 Spain Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 20 Asia Pacific Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 21 Japan Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 22 China Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 23 India Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 24 South Korea Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 25 Australia Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 26 Latin America Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 27 Brazil Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 28 Mexico Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 29 Argentina Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 30 MEA Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 31 South Africa Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 32 Saudi Arabia Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 33 UAE Coronary Stents market, by product, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity workflow analysis
  • Fig. 9 Market summary
  • Fig. 10 Coronary Stents market segmentation
  • Fig. 11 Parent Market Analysis
  • Fig. 12 Ancillary Market Analysis
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Incidence of CVDs in the U.S. in 2019
  • Fig. 15 Stent type and volume after price reduction in 2018
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Penetration & growth prospect mapping
  • Fig. 18 Consumer behavior analysis
  • Fig. 19 Market influencer analysis
  • Fig. 20 Coronary Stents technology timeline
  • Fig. 21 R&D expenditure analysis (2014 - 2019)
  • Fig. 22 SWOT analysis, by PEST
  • Fig. 23 Porter's Five Forces Analysis
  • Fig. 24 Market participant categorization
  • Fig. 25 Competitive dashboard analysis
  • Fig. 26 Company market share analysis
  • Fig. 27 Company market position analysis
  • Fig. 28 Heat map analysis
  • Fig. 29 Coronary stents market product outlook: Key takeaways
  • Fig. 30 Coronary stents market: Product movement analysis
  • Fig. 31 Bare Metal Stents market, 2016 - 2027 (USD Million)
  • Fig. 32 Drug eluting stents market, 2016 - 2027 (USD Million)
  • Fig. 33 Biodegradable drug eluting stents market, 2016 - 2027 (USD Million)
  • Fig. 34 Non-biodegradable drug eluting stents market, 2016 - 2027 (USD Million)
  • Fig. 35 Bioresorbable vascular scaffolds market, 2016 - 2027 (USD Million)
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 Regional Outlook, 2019 & 2027
  • Fig. 38 North America coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 39 U.S. coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 40 Canada Coronary Stents market, 2016 - 2027 (USD Million)
  • Fig. 41 Europe Coronary Stents market, 2016 - 2027 (USD Million)
  • Fig. 42 U.K. coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 43 Germany coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 44 France coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 45 Number of individuals suffering from heart disease, 2010 - 2017
  • Fig. 46 Italy coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 47 Spain coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 48 Asia Pacific Coronary Stents market, 2016 - 2027 (USD Million)
  • Fig. 49 Japan coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 50 China coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 51 India coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 52 South Korea coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 53 Australia coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 54 Latin America coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 55 Brazil coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 56 Mexico coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 57 Argentina coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 58 MEA coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 59 South Africa coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 60 Saudi Arabia coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 61 UAE coronary stents market, 2016 - 2027 (USD Million)
目次
Product Code: GVR-1-68038-106-1

The global coronary stents market size is expected to reach USD 11.3 billion by 2027, expanding at a CAGR of 4.7%, according to a new report by Grand View Research, Inc. Increasing adoption of minimally invasive surgeries and percutaneous coronary intervention (PIC) procedures is expected to drive the market for coronary stents in the coming years. Moreover, increasing geriatric population is considered as a high impact rendering driver for the growth of this industry over the forecast period. Technological advancement in 2nd generation drug eluting stents (DES) is further fueling the growth. Development of biodegradable and polymer free DES in order to increase patient compliance is expected to drive the market over the coming years.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare and Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service provider. From January 2020, Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in ambulatory surgical center (ASC), which is expected to boost market revenue over the forecast period.

Further key findings from the report suggest:

In terms of revenue, the DES dominated the product segment as of 2019. New product launches and technological advancements in 2nd gen DES are acting as the driving factor for this segment

Prices for the first-generation BVS (Bioresorbable Vascular Scaffold) are much high as compared to existing BMS (Bare Metal Stent) and DES. Due to its safety concern and high hospitalization rates, doctors are not preferring BRS over DES. Moreover, high crossing profile and bulky struts are factors majorly impeding the BRS market

Asia Pacific is expected to exhibit the highest growth rate over the forecast period. Increase in disposable income and growing incidence of heart diseases will fuel market growth in the coming years

Some of the key companies present in the coronary stent market are Medtronic, Abbott, Boston Scientific, Terumo Corporation, Biotronik, and Microport Corporation

With USD 2.3 billion R&D expenditure in 2018, Abbott is anticipated to provide with technologically advanced second generation DES and may be BVS in near future.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research Methodology
  • 1.2 Information Procurement
    • 1.2.1 Purchased Database:
    • 1.2.2 GVR's Internal Database
    • 1.2.3 Secondary Sources
    • 1.2.4 Primary Research:
    • 1.2.5 Details Of Primary Research
  • 1.3 Information or Data Analysis
    • 1.3.1 Data Analysis Models
  • 1.4 Market Formulation & Validation
  • 1.5 Model Details
    • 1.5.1 Commodity Workflow Analysis (Model 1)
  • 1.6 List of Secondary Sources
  • 1.7 List of Primary Sources
  • 1.8 Abbreviations
  • 1.9 Report Objectives

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Industry Outlook

  • 3.1 Market Segmentation
  • 3.2 Market Lineage Outlook
    • 3.2.1 Parent Market Analysis
    • 3.2.2 Ancillary Market Analysis
  • 3.3 Market Variable Analysis
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Rising burden of Cardiovascular Diseases (CVDs)
      • 3.3.1.2 Government initiatives to reduce cost of coronary stents
      • 3.3.1.3 Advancements in stenting technologies
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Stringent regulation and approval
      • 3.3.2.2 Product recall and failure
    • 3.3.3 Industry Chanllenges
      • 3.3.3.1 Risk associated with coronary stent post procedure
  • 3.4 Penetration & Growth Prospect Mapping
  • 3.5 User Perspective Analysis
    • 3.5.1 Consumer Behavior Analysis
    • 3.5.2 Market Influencer Analysis
  • 3.6 Pricing Analysis
  • 3.7 Technology Overview
  • 3.8 Regulatory Framework
    • 3.8.1 Regulatory Landscape
    • 3.8.2 Reimbursement Framework
      • 3.8.2.1 CPT Coding implications
      • 3.8.2.2 HCPCS Coding implications
    • 3.8.3 Cms New Reimbursement Policy For Pci
  • 3.9 Product Pipeline/Clinical Trial Analysis
  • 3.10 R&D Expenditure Analysis
  • 3.11 Estimated R&D Expenditure On Various Types Of Stents (2014 - 2019)
  • 3.12 Product Recalls
  • 3.13 Business Environment Analysis tools
    • 3.13.1 Swot Analysis, By Pest
    • 3.13.2 Porter's Five Forces Analysis

Chapter 4 Coronary Stents Market: Competitive Analysis

  • 4.1 Market Participation Categorization
  • 4.2 Competitive Dashboard Analysis
  • 4.3 Innovators
  • 4.4 Recent Innovations
  • 4.5 Public Companies
    • 4.5.1 Company Market Share Analysis
    • 4.5.2 Company Market Position Analysis
    • 4.5.3 Heat Map Analysis
  • 4.6 Vendor Landscape
    • 4.6.1 List Of Coronary Stent Providers

Chapter 5 Product Segment Analysis

  • 5.1 Coronary Stents Market: Product Movement Analysis
  • 5.2 Bare Metal Stents
    • 5.2.1 Bare Metal Stents Market, 2016 - 2027 (USD Million)
  • 5.3 Drug Eluting Stents
    • 5.3.1 Drug Eluting Stents Market, 2016 - 2027 (USD Million)
    • 5.3.2 Biodegradable Drug Eluting Stents
      • 5.3.2.1 biodegradable drug eluting stents market, 2016 - 2027 (USD Million)
    • 5.3.3 Non-Biodegradable Drug Eluting Stents
      • 5.3.3.1 non-biodegradable drug eluting stents market, 2016 - 2027 (USD Million)
  • 5.4 Bioresorbable Vascular Scaffolds
    • 5.4.1 Bioresorbable Vascular Scaffolds Market, 2016 - 2027 (USD Million)

Chapter 6 Coronary Stents Market: Regional Estimates & Trend Analysis, by Product

  • 6.1 Coronary Stents Market Share by Region, 2019 & 2027
  • 6.2 North America
    • 6.2.1 North America Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. Coronary Stents market, 2016 - 2027 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada Coronary Stents market, 2016 - 2027 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.3.2 U.K.
      • 6.3.2.1 U.K. coronary stents market, 2016 - 2027 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany coronary stents market, 2016 - 2027 (USD Million)
    • 6.3.4 France
      • 6.3.4.1 France coronary stents market, 2016 - 2027 (USD Million)
    • 6.3.5 Italy
      • 6.3.5.1 Italy coronary stents market, 2016 - 2027 (USD Million)
    • 6.3.6 Spain
      • 6.3.6.1 Spain coronary stents market, 2016 - 2027 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.4.2 Japan
      • 6.4.2.1 Japan coronary stents market, 2016 - 2027 (USD Million)
    • 6.4.3 China
      • 6.4.3.1 China coronary stents market, 2016 - 2027 (USD Million)
    • 6.4.4 India
      • 6.4.4.1 India coronary stents market, 2016 - 2027 (USD Million)
    • 6.4.5 South Korea
      • 6.4.5.1 South Korea coronary stents market, 2016 - 2027 (USD Million)
    • 6.4.6 Australia
      • 6.4.6.1 Australia coronary stents market, 2016 - 2027 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil coronary stents market, 2016 - 2027 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico coronary stents market, 2016 - 2027 (USD Million)
    • 6.5.4 Argentina
      • 6.5.4.1 Argentina coronary stents market, 2016 - 2027 (USD Million)
  • 6.6 MEA
    • 6.6.1 MEA Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa coronary stents market, 2016 - 2027 (USD Million)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia coronary stents market, 2016 - 2027 (USD Million)
    • 6.6.4 UAE
      • 6.6.4.1 UAE coronary stents market, 2016 - 2027 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Abbott
    • 7.1.1 Company Overview
    • 7.1.2 Financial Performance
    • 7.1.3 Product Benchmarking
    • 7.1.4 Strategic Initiatives
  • 7.2 Medtronic
    • 7.2.1 Company Overview
    • 7.2.2 Financial Performance
    • 7.2.3 Product Benchmarking
    • 7.2.4 Strategic Initiatives
  • 7.3 Boston Scientific Corporation
    • 7.3.1 Company Overview
    • 7.3.2 Financial Performance
    • 7.3.3 Product Benchmarking
    • 7.3.4 Strategic Initiatives
  • 7.4 Terumo Corporation
    • 7.4.1 Company Overview
    • 7.4.2 Financial Performance
    • 7.4.3 Product Benchmarking
    • 7.4.4 Strategic Initiatives
  • 7.5 B Braun Melsungen AG
    • 7.5.1 Company Overview
    • 7.5.2 Financial Performance
    • 7.5.3 Product Benchmarking
    • 7.5.4 Strategic Initiatives
  • 7.6 Biotronik
    • 7.6.1 Company Overview
    • 7.6.2 Financial Performance
    • 7.6.3 Product Benchmarking
    • 7.6.4 Strategic Initiatives
  • 7.7 Stentys SA
    • 7.7.1 Company Overview
    • 7.7.2 Financial Performance
    • 7.7.3 Product Benchmarking
    • 7.7.4 Strategic Initiatives
  • 7.8 MicroPort Scientific Corporation
    • 7.8.1 Company Overview
    • 7.8.2 Financial Performance
    • 7.8.3 Product Benchmarking
    • 7.8.4 Strategic Initiatives
  • 7.9 C. R. Bard, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Performance
    • 7.9.3 Product Benchmarking
    • 7.9.4 Strategic Initiatives
  • 7.10 Cook Medical
    • 7.10.1 Company Overview
    • 7.10.2 Product Benchmarking
    • 7.10.3 Strategic Initiatives